ES2231176T3 - Uso de beta-(1,3)-glucanos nanometricos hidrosolubles. - Google Patents

Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.

Info

Publication number
ES2231176T3
ES2231176T3 ES00916895T ES00916895T ES2231176T3 ES 2231176 T3 ES2231176 T3 ES 2231176T3 ES 00916895 T ES00916895 T ES 00916895T ES 00916895 T ES00916895 T ES 00916895T ES 2231176 T3 ES2231176 T3 ES 2231176T3
Authority
ES
Spain
Prior art keywords
nanometric
glanes
hydrosolubles
beta
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00916895T
Other languages
English (en)
Inventor
Christian Kropf
Ute Griesbach
Bernd Fabry
Rolf E Engstad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arcticzymes Technologies ASA
Original Assignee
Biotec Pharmacon ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotec Pharmacon ASA filed Critical Biotec Pharmacon ASA
Application granted granted Critical
Publication of ES2231176T3 publication Critical patent/ES2231176T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/65Characterized by the composition of the particulate/core
    • A61K2800/654The particulate/core comprising macromolecular material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

Uso de â-(1, 3)-glucanos hidrosolubles nanométricos que están sustancialmente exentos de enlaces â-(1, 6) y muestran un diámetro de partículas en el intervalo de 10 a 300 nm, para la preparación de preparaciones cosméticas y/o farmacéuticas.
ES00916895T 1999-03-12 2000-03-03 Uso de beta-(1,3)-glucanos nanometricos hidrosolubles. Expired - Lifetime ES2231176T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19911058A DE19911058B4 (de) 1999-03-12 1999-03-12 Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen

Publications (1)

Publication Number Publication Date
ES2231176T3 true ES2231176T3 (es) 2005-05-16

Family

ID=7900743

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00916895T Expired - Lifetime ES2231176T3 (es) 1999-03-12 2000-03-03 Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.

Country Status (11)

Country Link
US (1) US6858214B1 (es)
EP (1) EP1165037B1 (es)
JP (1) JP2002539147A (es)
KR (1) KR20010108349A (es)
CN (1) CN1182834C (es)
AT (1) ATE286713T1 (es)
AU (1) AU775786B2 (es)
CA (1) CA2367875A1 (es)
DE (2) DE19911058B4 (es)
ES (1) ES2231176T3 (es)
WO (1) WO2000054741A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19911057C2 (de) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Haarkosmetische Zubereitungen
US6649154B1 (en) * 1999-06-03 2003-11-18 Shiseido Co., Ltd. Hairdressing cosmetic preparation and hairdressing method using the same
DE60218299T2 (de) * 2001-04-27 2007-10-31 Ajinomoto Co., Inc. Eine Dispersion aus Beta-Glukan enthaltenden hochfeinen Partikel, ein entsprechender Herstellungsprozess und die Verwendung der Dispersion
JP4752233B2 (ja) * 2001-04-27 2011-08-17 味の素株式会社 免疫賦活剤
EP1550429B1 (en) * 2002-05-09 2010-11-17 Shiseido Company, Ltd. External preparations for skin
JP2004051561A (ja) * 2002-07-22 2004-02-19 Shiyuu Uemura Keshohin:Kk 皮膚化粧料組成物
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
CN101184780B (zh) * 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
CN1877239A (zh) * 2005-06-08 2006-12-13 鸿富锦精密工业(深圳)有限公司 热管工作流体及其制备方法
CN1948421B (zh) * 2005-10-13 2010-05-26 鸿富锦精密工业(深圳)有限公司 工作流体
WO2009111685A1 (en) 2008-03-06 2009-09-11 Sensient Flavors Llc Herbal extracts and flavor systems for oral products and methods of making the same
US8394421B2 (en) * 2008-07-30 2013-03-12 The Board Of Trustees Of The University Of Illinois Synthesis of nanoparticles by fungi
US20100267661A1 (en) * 2009-03-17 2010-10-21 Immudyne, Inc. Beta glucans and methods of use thereof
CN103301040B (zh) * 2013-06-29 2015-01-21 安徽省林锦记食品工业有限公司 小麦蛋白护发素
JP7274863B2 (ja) * 2016-09-30 2023-05-17 合同会社レビアスファーマ 粒子およびその製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5527126A (en) 1978-08-16 1980-02-27 Asahi Chem Ind Co Ltd Cosmetic base
JPS56135416A (en) * 1980-03-27 1981-10-22 Mitsubishi Chem Ind Ltd Pharmaceutical preparation for skin
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
JPH03204804A (ja) * 1989-12-28 1991-09-06 Mitsui Toatsu Chem Inc 皮膚化粧料
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
FR2681248B1 (fr) * 1991-09-13 1995-04-28 Oreal Composition pour un traitement cosmetique et/ou pharmaceutique de longue duree des couches superieures de l'epiderme par une application topique sur la peau.
AU2764592A (en) * 1991-10-15 1993-05-21 Fmc Corporation Beta -1,3-glucan polysaccharides, compositions, and their preparation and uses
US5376173A (en) * 1992-09-17 1994-12-27 Takeda Chemical Industries, Ltd. Segregation reducing agent for hydraulic composition and hydraulic composition
NO300692B1 (no) * 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
DE19537509A1 (de) * 1995-09-27 1997-04-10 Egsto Pharm Pharmazeutische Pr Hautpflegemittel
CA2234957C (en) * 1995-10-17 2006-12-19 Inge B. Henriksen Insoluble drug delivery
FR2750864B1 (fr) * 1996-07-10 1999-04-16 Oreal Utilisation d'un polyholoside dans une composition destinee a stimuler les defenses immunitaires, et composition le comprenant
DE19710368A1 (de) * 1997-03-13 1998-09-17 Henkel Kgaa Verwendung von wasserlöslichen beta-Glucanen als Wirkstoffe zur Herstellung von therapeutischen Mitteln zur Hautbehandlung
EP0875244B1 (en) * 1997-05-02 2007-09-12 Ciba SC Holding AG Cosmetically accceptable microstructured compositions
DE19737481A1 (de) 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel
US6143883A (en) * 1998-12-31 2000-11-07 Marlyn Nutraceuticals, Inc. Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system
DE19911057C2 (de) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Haarkosmetische Zubereitungen

Also Published As

Publication number Publication date
AU775786B2 (en) 2004-08-12
AU3808400A (en) 2000-10-04
ATE286713T1 (de) 2005-01-15
DE19911058B4 (de) 2004-09-30
CN1182834C (zh) 2005-01-05
EP1165037B1 (de) 2005-01-12
JP2002539147A (ja) 2002-11-19
KR20010108349A (ko) 2001-12-07
WO2000054741A1 (de) 2000-09-21
EP1165037A1 (de) 2002-01-02
DE50009222D1 (de) 2005-02-17
CN1347307A (zh) 2002-05-01
DE19911058A1 (de) 2000-09-21
US6858214B1 (en) 2005-02-22
CA2367875A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
ES2231176T3 (es) Uso de beta-(1,3)-glucanos nanometricos hidrosolubles.
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
DE60226613D1 (de) Darreichungsformen welche mikropartikel und treibgas enthalten
ES2235311T8 (es) Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma.
AR018635A1 (es) Producto alimenticio basado en soja, estable, enriquecido con calcio y uso del producto liquido
AR044520A1 (es) Composicion cosmetica en forma de una emulsion de agua y aceite, procedimiento para prepararla, producto cosmetico que comprende dicha composicion y uso.
BRPI0214264B8 (pt) composição, processos para sua preparação e usos de uma composição
ES2138441T3 (es) Polvo de polimero redispersable y dispersiones acuosas de polimero que pueden obtenerse a partir del mismo.
ES2059674T3 (es) Uso de una composicion como un producto cosmetico.
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
SV2002000776A (es) Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv
PT1112266E (pt) 4-amino-2-aril-pirimidinas substituidas, sua preparacao, sua utilizacao e composicoes farmaceuticas que as contem.
ITMI941446A0 (it) Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico
IT1290856B1 (it) Metalloceni, loro preparazione ed uso nella polimerizzazione di alfa-olefine
UY27458A1 (es) Tetrahidroquinolinas
BR0114814A (pt) Composições compreendendo composto de modafinila e seu uso
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
ITRM950037A0 (it) Uso della carnitina e i suoi derivati per ridurre gli effetti tossici della ciclosporina-a e di altri farmaci immunosoppressivi.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
WO1998031712A3 (en) Chitosan-conjugates with acidic chelate-complex forming agents
PT1275647E (pt) Derivados de octa-hidro-2h-pirido¬1,2-a|pirazina processo para a sua preparacao e as composicoes farmaceuticas que os contem
MD970269A (en) Clavulanates
IL105947A (en) Preparation of melanin in fluorocarbons for topical use and its production
PA8454301A1 (es) Composiciones solubilizadas de sertralina